|HQ||San Francisco, US||Map|
|Employees (est.) (Nov 2017)||125||(+3%)|
|Share Price (Feb 2019)||$21||(+5%)|
Net income (Q2, 2018)
EBIT (Q2, 2018)
Market capitalization (15-Feb-2019)
Closing stock price (15-Feb-2019)
|USD||FY, 2015||FY, 2016||FY, 2017|
Depreciation and Amortization
Cash From Operating Activities
When was Denali Therapeutics founded?
Denali Therapeutics was founded in 2015.
Who are Denali Therapeutics key executives?
Denali Therapeutics's key executives are Ryan Watts, Alexander Schuth and Carole Ho.
How many employees does Denali Therapeutics have?
Denali Therapeutics has 125 employees.
Who are Denali Therapeutics competitors?
Competitors of Denali Therapeutics include 23andMe, Stealth BioTherapeutics and Orchard Therapeutics.
Where is Denali Therapeutics headquarters?
Denali Therapeutics headquarters is located at 151 Oyster Point Blvd, San Francisco.
Where are Denali Therapeutics offices?
Denali Therapeutics has an office in San Francisco.
How many offices does Denali Therapeutics have?
Denali Therapeutics has 1 office.